Sfoglia per Autore
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis
2007 L. Valenti, E.A. Pulixi, P. Arosio, L. Cremonesi, G. Biasiotto, P. Dongiovanni, M. Maggioni, S. Fargion, A.L. Fracanzani
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients
2007 L.V.C. Valenti, G. Valenti, G. Como, L. Burdick, G. Santorelli, P. Dongiovanni, R. Rametta, F. Bamonti, C. Novembrino, A.L. Fracanzani, P.G. Messa, S. Fargion, P. Messa
Iron status modulates the expression of the ubiquitin ligase MDM-2 and its target p53 in mouse hepatocytes and human monocytes; Effect on the anti-oxidant response
2007 L. Valenti, P. Dongiovanni, C. Megazzini, A.L. Fracanzani, S. Fargion
Inherited variants of genes involved in insulin signaling and lipogenesis influence the risk of hepatic fibrosis in nonalcoholic fatty liver disease
2007 P. Dongiovanni, L. Valenti, R. Rametta, A.L. Fracanzani, S. Fargion
Role of TRB3 in the regulation of hepatic lipogenesis in nonalcoholic fatty liver disease
2007 L. Valenti, R. Rametta, P. Dongiovanni, A.L. Fracanzani, S. Fargion
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcholic fatty liver disease and hyperfettitinemia; evidence from a case control study
2007 L. Valenti, A.L. Fracanzani, P. Dongiovanni, E. Bugianesi, E. Vanni, G. Marchesini, S. Fargion
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia : evidence from a case-control study
2007 L.V.C. Valenti, A.L. Fracanzani, P. Dongiovanni, E. Bugianesi, G. Marchesini, P. Manzini, E. Vanni, S.R. Fargion
Iron depletion by phlebotomy improves insulin resistance in patients with non alcoholic fatty liver disease and hyperferritinemia ; evidence from a multicenter case control study
2007 L. Valenti, E. Remondini, P. Dongiovanni, E. Bugianesi, S. Fargion
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease
2007 L. Valenti, P. Dongiovanni, A. Piperno, A.L. Fracanzani, R. Rametta, P. Trombini, S. Fargion
Serum ferritin, is associated with iron availability, decreased anti-oxidant potemtial and HFE gene mutations, and a risk factor for cardiovascular damage in hemodialysis patients
2007 L. Valenti, G. Valenti, G. Como, L. Burdick, G. Santarelli, P. Dongiovanni, A.L. Fracanzani, P.G. Messa, S. Fargion
Hepatic expression of the forkhead transcription factor Fox01 is increased in non-alcoholic steatohepatitis and associated with enhanced glucogenesis and insulin resistance
2007 L. Valenti, R. Rametta, P. Dongiovanni, A.L. Fracanzani, S. Fargion
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes
2007 L. Valenti, P. Dongiovanni, C. Magazzini, R. Rametta, A.L. Fracanzani, S. Fargion
Relative contribution of iron genes, dysmetabolism and hcv in the pathogenesis of altered iron regulation in chronic hepatitis C
2007 L. Valenti, E.A. Pulixi, P. Arosio, L. Cremonesi, G. Biasiotto, P. Dongiovanni, M. Maggioni, S. Fargion, A.L. Fracanzani
The hdm-2/p53 pathway is regulated by iron status in hepatocytes and human monocytes and hdm-2 genotype affects the risk of hepatocellular carcinoma during iron overload
2007 L. Valenti, P. Dongiovanni, C. Megazzini, M. Ravani, A.L. Fracanzani, S. Fargion
Hfe genotype influences erythropoiesis support requiement in hemodialysis patients: a prospective study.
2007 L. Valenti, G. Valenti, G. Como, G. Santarelli, P. Dongiovanni, R. Rametta, A.L. Fracanzani, D. Tavazzi, P.G. Messa, S. Fargion
Inherited variants of genes involved in insulin signalic and lipogenesis influence the risk of hepatic fibrosis in nonalcoholic fatty liver disease
2007 L. Valenti, P. Dongiovanni, R. Rametta, A.L. Fracanzani, S. Fargion
Role of TRB3 in the regulation of hepatic lipogenesis in non alcoholic fatty liver disease
2007 L. Valenti, R. Rametta, P. Dongiovanni, A.L. Fracanzani, S. Fargion
Increased expression and activity of the transcription factor foxol in non-alcoholic steatohepatitis
2007 L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, S. Fargion
Inherited variants of genes involved in insulin signaling affect the risk of hepatic fibrosis in NAFLD
2007 P. Dongiovanni, L. Valenti, R. Rametta, A.L. Fracanzani, S. Fargion
HFE Genotype influences erythropoiesis support requirement in hemodialysis patients : a prospective study
2007 L. Valenti, G. Valenti, G. Como, G. Santorelli, P. Dongiovanni, R. Rametta, A.L. Fracanzani, D. Tavazzi, P.G. Messa, S. Fargion
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile